A Study Evaluating a New Radiation Treatment Workflow (NGDS)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at delivering radiation in shorter treatment time and better patient tolerance, with less breath holding.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Guz w klatce piersiowej lub górnej części brzucha
- •Pacjent ma otrzymać napromieniowanie SBRT na urządzeniu z systemem C-arm lub pierścieniowym
- •Wiek co najmniej 21 lat
- •Dobry ogólny stan zdrowia (ECOG 0-1)
- •Zdolność do podpisania zgody na udział w badaniu
✗ Disqualifies
- •Jednoczesny udział w innym badaniu klinicznym, które mogłoby kolidować z tym badaniem
- •Inne problemy zdrowotne lub wyniki badań, które mogą uniemożliwić udział w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 21 Years
- Last updated (source)
- September 17, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (2)
Siteman Cancer Center Washington University
St Louis, United States
University Hospital Cleveland Medical Center
Cleveland, United States
Trial contact
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.